Details
Question
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with early breast cancer (EBC)?
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with metastatic breast cancer (MBC)?
- What is the clinical effectiveness of switching from Herceptin or other biosimilars to Ogivri for patients with metastatic gastric cancer (MGC)?